- Home
- / Satellos Bioscience
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Satellos Bioscience financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
CreditSafe Score
?
Score changed on Jun 05, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Gross profit | 504.0K | |||||||
| Operating expense total | 2.2M | 1.1M | 1.0M | 3.1M | 6.5M | 13.0M | 18.7M | 24.1M |
| Depreciation and amortization | 2.0K | 3.0K | 3.0K | 166.0K | 3.2M | 7.0K | 2.9M | 5.0K |
| EBITDA | (1.7M) | (1.1M) | (1.0M) | (3.1M) | (6.5M) | (13.0M) | (18.7M) | (24.1M) |
| EBIT | (1.7M) | (1.1M) | (1.0M) | (12.9M) | (9.7M) | (13.5M) | (21.6M) | (24.1M) |
| Interest income | 8.0K | 63.0K | 1.3M | 1.4M | ||||
| Interest expense | 985.0K | 177.0K | ||||||
| Pre tax profit | (1.7M) | (2.2M) | (1.7M) | (15.5M) | (11.3M) | (15.9M) | (20.6M) | (24.7M) |
| Income tax expense | (265.0K) | (164.0K) | 5.0K | 172.0K | ||||
| Net Income | (1.7M) | (1.9M) | (1.5M) | (15.5M) | (11.3M) | (15.9M) | (20.6M) | (24.9M) |